

Author: Illek B. Machen T.E. Widdicombe J. Fischer H.
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 1-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cystic fibrosis transmembrane regulator (CFTR) modulators
Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 4, 2005-04 ,pp. :




By Gallati Sabina Hess Simone Galié-Wunder Dorothea Berger-Menz Elisabeth Böhlen Dominik
Reproductive BioMedicine Online, Vol. 19, Iss. 5, 2009-11 ,pp. :

